Clinical Autonomic Research
Volume 15, Number 1, 51-53, DOI: 10.1007/s10286-005-0225-3

SHORT COMMUNICATION

Pyridostigmine for treatment of neurogenic orthostatic hypertension
A follow-up survey study

Paola Sandroni, Tonette L. Opfer-Gehrking, Wolfgang Singer and Phillip A. Low

View Related Documents

Abstract

We report the result of a follow-up, open-label study of pyridostigmine for treatment of orthostatic hypotension. Aim of the study was to evaluate self-reported efficacy and patientsrsquo satisfaction with the medication. Most patients were very satisfied with the medication and chose to continue it.

Key words   orthostatic hypotension - pyridostigmine

This study was supported in part from grants from the National Institutes of Health, Bethesda, MD: 5 K23 RR15537 (Dr. Sandroni), NS3 2352, NS4 4233 NS4 3364 (Dr. Low), and Mayo GCRC grant M01-RR00585

Fulltext Preview

Image of the first page of the fulltext document